Tag: Rentscghler

August 23, 2023 Off

Rentschler Biopharma, Cell and Gene Therapy Catapult and Refeyn in collaboration

By Dino Mustafić

Rentschler Biopharma, a leading global contract development and manufacturing organisation (CDMO) for biopharmaceuticals, including advanced therapy medicinal products (ATMPs), announces a collaboration with the Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in the advancement of cell and gene therapies, and Refeyn Ltd., the Oxford based mass photometry pioneer.